Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
2004 1
2006 1
2007 2
2008 2
2010 1
2011 1
2013 4
2014 1
2015 1
2016 2
2017 2
2018 1
2019 2
2020 1
2022 1
2023 2
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Döhner H, Weber D, Krzykalla J, Fiedler W, Kühn MWM, Schroeder T, Mayer K, Lübbert M, Wattad M, Götze K, Fransecky L, Koller E, Wulf G, Schleicher J, Ringhoffer M, Greil R, Hertenstein B, Krauter J, Martens UM, Nachbaur D, Samra MA, Machherndl-Spandl S, Basara N, Leis C, Schrade A, Kapp-Schwoerer S, Cocciardi S, Bullinger L, Thol F, Heuser M, Paschka P, Gaidzik VI, Saadati M, Benner A, Schlenk RF, Döhner K, Ganser A; German–Austrian AML Study Group. Döhner H, et al. Among authors: samra ma. Lancet Haematol. 2023 Jul;10(7):e495-e509. doi: 10.1016/S2352-3026(23)00089-3. Epub 2023 May 12. Lancet Haematol. 2023. PMID: 37187198 Clinical Trial.
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
Rücker FG, Corbacioglu A, Krzykalla J, Cocciardi S, Lengerke C, Germing U, Wulf G, Samra MA, Teichmann LL, Lübbert M, Kühn MWM, Bentz M, Westermann J, Bullinger L, Gaidzik VI, Meid A, Aicher S, Stegelmann F, Weber D, Schrade A, Thol F, Heuser M, Ganser A, Benner A, Döhner H, Döhner K; German‐Austrian Acute Myeloid Leukemia Study Group (AMLSG). Rücker FG, et al. Among authors: samra ma. Hemasphere. 2024 Jul 15;8(7):e123. doi: 10.1002/hem3.123. eCollection 2024 Jul. Hemasphere. 2024. PMID: 39011127 Free PMC article. No abstract available.
Hematologic malignancies during pregnancy: A review.
Mahmoud HK, Samra MA, Fathy GM. Mahmoud HK, et al. Among authors: samra ma. J Adv Res. 2016 Jul;7(4):589-96. doi: 10.1016/j.jare.2016.02.001. Epub 2016 Feb 8. J Adv Res. 2016. PMID: 27408762 Free PMC article. Review.
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
Shouman MT, Mansour OM, El Gammal MM, Abdel-Fattah RM, Samra MA, Elhaddad AM, Maher MA, Mahmoud HK. Shouman MT, et al. Among authors: samra ma. Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):379-387. doi: 10.56875/2589-0646.1065. Hematol Oncol Stem Cell Ther. 2023. PMID: 37363983 Free article.
MPN10 score and survival of molecularly annotated myeloproliferative neoplasm patients.
ElNahass YH, Mahmoud HK, Mattar MM, Fahmy OA, Samra MA, Abdelfattah RM, ElRefaey FA, Fahmy HM, Fathy GM, Abdulgawad A, AbdelKader M, Elleithy HN, Gamil M, Talaat M, Nader HA, ElMetnawy WH. ElNahass YH, et al. Among authors: samra ma. Leuk Lymphoma. 2018 Apr;59(4):844-854. doi: 10.1080/10428194.2017.1365852. Epub 2017 Aug 22. Leuk Lymphoma. 2018. PMID: 28828906
28 results